Patrick Fabbio Insider Profile
11 Followers
Patrick Fabbio, Director at Beyondspring, holds ― shares in Beyondspring (Ticker: BYSI), holds 0.00 shares in Progenics (Ticker: PGNX), holds 64.11K shares in Protara Therapeutics (Ticker: TARA). Most recently, Patrick Fabbio ― shares of Beyondspring on ― for an estimated value of ―.
Patrick Fabbio has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Patrick Fabbio holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Patrick Fabbio
Patrick Fabbio's Trading History
Beyondspring
―
Director
―
―
Progenics
―
―
―
$0.00
Rafael Holdings
Dec 23, 2022
CFO & President
Uninformative Sell
49.15K
$687.11K
Protara Therapeutics
Jan 27, 2026
CFO
Uninformative Sell
21.75K
$227.61K
List of latest transactions for each holding click on a transaction to see Patrick Fabbio's performance on stock
You May Also Like
Patrick Fabbio insider profile FAQ
What is the percentage of profitable transactions made by Patrick Fabbio?
The percentage of profitable transactions made by Patrick Fabbio is ―.
What is the average return per transaction made by Patrick Fabbio?
The average return per transaction made by Patrick Fabbio is ―.
What stocks does Patrick Fabbio hold?
Patrick Fabbio holds: BYSI, PGNX, RFL, TARA stocks.
What was Patrick Fabbio’s latest transaction?
Patrick Fabbio latest transaction was an Uninformative Buy of ―.
What was Patrick Fabbio's most profitable transaction?
Patrick Fabbio’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Patrick Fabbio's role in Beyondspring?
Patrick Fabbio's role in Beyondspring is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.